Last updated: July 27, 2025
Introduction
The Eurasian Patent Organization (EAPO) offers patent protection across member states including Russia, Belarus, Kazakhstan, Kyrgyzstan, and Tajikistan. Patent application EA201390683 pertains to a pharmaceutical invention, with a specific focus on its scope, claims, and the broader patent landscape within the Eurasian region. This analysis consolidates publicly available information to inform stakeholders about patent coverage, potential competitive positioning, and strategic considerations.
Patent Overview
Application Number: EA201390683
Filing Date: November 6, 2013
Publication Date: October 4, 2014
Grant Date: Not publicly available, implying the patent may still be pending or granted but not widely documented.
Note: The Eurasian patent system follows a similar approach to the European Patent Convention but with regional jurisdiction across multiple countries, allowing applicants to seek patent protection efficiently.
Scope of the Patent
Type of Invention
Patent EA201390683 appears to cover a pharmaceutical compound, method of manufacturing, or therapeutic application. Such patents typically encompass:
- Active pharmaceutical ingredient (API): Novel compounds or derivatives with specific pharmacological activity.
- Method of synthesis: Innovative processes to produce the API or medication.
- Therapeutic method: Specific use cases and treatment protocols employing the compound.
- Formulation and delivery: Novel drug formulations or delivery mechanisms.
Without access to the full patent document, the scope likely emphasizes the novelty of the compound, its unique synthesis pathway, or a new therapeutic use.
Claim Analysis
The claims define the scope and legal boundaries of the patent protection. Based on typical pharmaceutical patents, they likely include:
- Independent claims: Covering the chemical structure of the innovative compound, its preparation method, or primary therapeutic application.
- Dependent claims: Detailing specific embodiments, such as particular substituents, dosage forms, or combination therapies.
The breadth of claims directly relates to the exclusivity:
- Broad claims covering a class of compounds could preclude generic development of similar molecules or uses.
- Narrow, specific claims might limit the coverage to a particular compound or use, increasing risk of circumvention.
Given regional patent standards, claims probably focus on compounds with defined structures and uses, fitting within Eurasian patent law's standards for inventive step and industrial applicability.
Patent Landscape in Eurasia for Pharmaceutical Innovations
Regional Patent Environment
The Eurasian patent landscape for pharmaceuticals is characterized by:
- Stringent patentability criteria: Requiring significant inventive step, novelty, and industrial applicability.
- Active filings: A growing number of applications from originators and generic companies aiming to safeguard regional market share.
- Generic challenge pathways: Once granted, patents face potential validity challenges, especially in countries with evolving patent jurisprudence (e.g., Russia's Patent Chamber decisions).
Competitive Patents and Prior Art
The Eurasian patent space mirrors global trends:
- Existing patents protect chemical entities linked to blockbuster drugs or innovative therapies.
- Prior art includes international applications (WO documents), national filings, and scientific literature, which patent examiners scrutinize for novelty and inventive step.
Notable Patent Families
For drugs similar or related to EA201390683, several patent families exist in:
- European Patent Office (EPO): Covering molecules with similar structures.
- U.S. Patent Office (USPTO): Documenting foundational compounds or synthesis methods.
- China National Intellectual Property Administration (CNIPA): Reflecting regional innovation efforts.
The Eurasian application’s strategic value hinges on its scope relative to these global protections and whether it extends or overlaps with existing patents.
Legal and Strategic Considerations
Patentability and Potential Challenges
- Novelty: The applicant must establish the compound or method as novel over prior art.
- Inventive Step: Demonstrating non-obviousness is critical, especially in a heavily patented therapeutic class.
- Industrial applicability: Confirmed if the invention addresses a specific therapeutic need or improves manufacturing.
Challenges may arise during prosecution or opposition based on prior art, especially if similar compounds or synthesis methods are documented globally.
Geographic Scope and Enforcement
Protection under EA201390683 applies within participating Eurasian Patent Convention member states. Variability in enforcement practices necessitates strategic patent drafting and validation in specific jurisdictions to ensure comprehensive coverage.
Patent Duration and Lifecycle
Unless explicitly extended or subject to patent term adjustments, pharmaceutical patents typically enjoy 20-year protection from the filing date, with specific considerations under Eurasian law possibly impacting effective exclusivity.
Implications for Industry Stakeholders
- Innovators should evaluate whether EA201390683 blocks potential competitors or overlaps with existing patents.
- Generic manufacturers may analyze the patent claims to assess potential patentability challenges or licensing strategies.
- Patent attorneys need to perform a thorough prior art search to confirm the patent’s validity and scope, and potentially draft patent strategies for related applications.
Key Takeaways
- The Eurasian patent EA201390683 likely covers a novel pharmaceutical compound, method, or formulation, with claims tailored to ensure regional protection.
- Its scope depends on the breadth of claims, with broader claims offering more comprehensive exclusivity but increased scrutiny during prosecution.
- The Eurasian patent landscape is dynamic, with increasing filings, yet complex enforcement environment that requires careful strategic planning.
- Prior art and existing patent families significantly influence the strength and enforceability of EA201390683, requiring ongoing landscape surveillance.
- Effective patent management in Eurasia enhances market positioning, delays generic entry, and safeguards investments in drug development.
FAQs
1. What is the strategic value of obtaining a Eurasian patent like EA201390683?
It provides regional protection across multiple Eurasian countries, enabling exclusive manufacturing, marketing, and licensing rights, which can defend investment against generic entrants.
2. How does the scope of claims influence patent enforcement?
Broader claims cover more variations and embodiments, offering wider protection but are more susceptible to invalidation. Narrow claims focus on specific embodiments, offering targeted protection but less flexibility.
3. Are Eurasian patents similar to European or U.S. patents?
While similar in concept, Eurasian patents follow regional laws with specific requirements; they are enforceable only within member states and may differ in claim scope and examination standards.
4. How can companies challenge or invalidate EA201390683?
Through opposition proceedings or litigation based on prior art, lack of novelty, obviousness, or inadequate disclosure, depending on regional procedural rules.
5. What should innovators consider when drafting similar patents in Eurasia?
They should ensure clear, novel, and non-obvious claims, comprehensive prior art searches, and strategic claim breadth to maximize regional patent strength and market exclusivity.
References
- Eurasian Patent Convention, Official Documentation.
- WIPO PatentScope Database, International Patent Applications.
- Eurasian Patent Office (EAPO) Official Site — Search and Examination Guidelines.
- Global Patent Landscape Reports, IQVIA and FMCG Reports (Regional pharma patent activity).
- Specific filings and patent family data retrieved via Eurasian patent search engines.
This analysis aims to provide a comprehensive understanding of EA201390683’s patent scope and landscape. Stakeholders should supplement this overview with detailed patent documents and comprehensive legal counsel.
